The market is witnessing steady growth due to rising pet ownership, increasing animal healthcare expenditure, and strong demand for early disease detection. Growth in the adoption of advanced diagnostic technologies, including point-of-care and molecular testing, continues to support market expansion across the country.
U.S. Veterinary diagnostics refers to the testing and diagnostic services used to detect, monitor, and manage diseases in animals across the United States. It includes laboratory testing, imaging, and rapid diagnostic tools for pets and livestock. The U.S. veterinary diagnostics market is growing due to rising pet ownership, increasing spending on companion animal healthcare, and greater awareness of preventive diagnostics. Strong adoption of advanced technologies such as point-of-care testing, molecular diagnostics, and digital imaging is further supporting market expansion. In addition, the increasing prevalence of chronic, infectious, and age-related diseases in animal countries will drive sustained demand across veterinary hospitals and clinics.
The global veterinary diagnostics market size was estimated at USD 11.8 billion in 2025 and is predicted to increase from USD 12.89 billion in 2026 to approximately USD 28.45 billion by 2035, expanding at a CAGR of 9.2% from 2026 to 2035
The U.S. market offers strong future opportunities in AI-powered diagnostics, point-of-care testing, and tele-veterinary solutions, driven by rising demand for faster and more accurate animal disease detection. Expansion into home-based testing and advanced molecular diagnostics is expected to create a significant growth avenue. Recently, companies have increased investments in digital diagnostic platforms and mobile veterinary testing services, further strengthening future market potential.
| Segment | Numerical Data |
| NAHLN Laboratories | 65 laboratories |
| NVSL Federal Units | 4 Units |
| Veterinary Clinics & Hospitals | 70,000-90,000 facilities |
| Pet Owning Households | 60-70 million households |
| Cattle Population | 87 million animals |
The U.S. veterinary diagnostics market is supported by a strong national laboratory network, large per-household ownership, and a significant livestock population. Continuous diagnostic testing across clinics and federal surveillance systems drives consistent demand for advanced animal health monitoring and disease detection.
The consumables segment dominated the U.S. veterinary diagnostics market with a share of 52% in 2025 due to the high recurring demand for test kits, assay cartridges, and sample collection supplies used sample collection supplies used in routine animal testing. Their frequent replacements, widespread use in clinics and laboratories, and rising volumes of diagnostic procedures for companion and livestock animals significantly supported the segment’s leading market share.
The immunodiagnostics segment led the U.S. veterinary diagnostics market with a share of 34% in 2025 due to its extensive use in detecting infectious diseases, hormonal imbalances, and immune-related disorders in animals. These tests offer fast, accurate, and cost-effective results, making them widely adopted across veterinary clinics and diagnostic laboratories for routine screening and early disease diagnosis.
The companion animals segment held a dominant share of 64% in veterinary diagnostics in 2025 due to rising pet ownership, higher spending on pet health care, and increasing demand for routine health screening. Frequent diagnostic testing for dogs, cats, and other pets, along with growing awareness of preventive care and early disease detection, significantly strengthened the segment’s market leadership.
The infectious disease segment led the U.S. veterinary diagnostics market with a share of 38% in 2025 due to the high incidence of bacterial, viral, and parasitic infections in companion and livestock animals. Growing focus on early diagnosis, timely treatments, and prevention of disease transmission, including zoonotic infections, has significantly increased demand for advanced diagnostic testing across veterinary hospitals and laboratories.
The veterinary hospitals & clinics segment held a dominant share of 48% in 2025 due to the high volume of animal visits for routine checkups, diagnostics, treatment, and emergency care. These facilities are equipped with advanced testing instruments and skilled professionals, enabling faster and accurate diagnosis, which continues to drive strong demand and market leadership.
Leading companies in the market include IDEXX Laboratories, Zoetis, Mars Petcare (Antech Diagnostics), Thermo Fisher Scientific, Heska Corporation, Neogen Corporation, Virbac, Embark Veterinary, Agrolabo S.p.A., and Fujifilm Vet Systems. These companies dominate through broad portfolios of in-clinic analyzers, rapid test kits, molecular diagnostics, imaging systems, genetic testing, and laboratory services, driving innovation in animal health diagnostics and preventive veterinary care.
By Product Type
By Technology
By Animal Type
By Application
By End User
